Literature DB >> 17371982

Suppression of memory CD8 T cell generation and function by tryptophan catabolism.

Zhiwei Liu1, Hehua Dai, Ni Wan, Tao Wang, Suzanne Bertera, Massimo Trucco, Zhenhua Dai.   

Abstract

Dendritic cell-derived indoleamine 2,3-dioxygenase (IDO) suppresses naive T cell proliferation and induces their apoptosis by catalyzing tryptophan, and hence is essential for the maintenance of peripheral tolerance. However, it is not known whether memory T cells are subject to the regulation by IDO-mediated tryptophan catabolism, as memory T cells respond more rapidly and vigorously than their naive counterparts and are resistant to conventional costimulatory blockade. In this study, we present the evidence that memory CD8+ T cells are susceptible to tryptophan catabolism mediated by IDO. We found that overexpression of IDO in vivo attenuated the generation of both central memory CD8+ T cells (T(CM)) and effector memory CD8+ T cells (T(EM)) while suppressing IDO activity promoted their generation. Moreover, IDO overexpression suppressed the effector function of T(CM) cells or T(CM) cell-mediated allograft rejection as well as their proliferation in vivo. Interestingly, T(CM) cells were resistant to apoptosis induced by tryptophan catabolism. However, IDO overexpression did not suppress the effector function of T(EM) cells or T(EM) cell-mediated allograft rejection, suggesting that T(EM) cells, unlike T(CM) cells, do not require tryptophan for their effector function once they are generated. This study provides insight into the mechanisms underlying the differential regulation of memory T cell responsiveness and has clinical implications for vaccination or tolerance induction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17371982     DOI: 10.4049/jimmunol.178.7.4260

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Central role of IFNgamma-indoleamine 2,3-dioxygenase axis in regulation of interleukin-12-mediated antitumor immunity.

Authors:  Tao Gu; Rachael B Rowswell-Turner; Mehmet O Kilinc; Nejat K Egilmez
Journal:  Cancer Res       Date:  2009-12-22       Impact factor: 12.701

2.  In vivo metabolism of tryptophan in meningiomas is mediated by indoleamine 2,3-dioxygenase 1.

Authors:  Ian M Zitron; David O Kamson; Sam Kiousis; Csaba Juhász; Sandeep Mittal
Journal:  Cancer Biol Ther       Date:  2013-01-28       Impact factor: 4.742

3.  The subsets of dendritic cells and memory T cells correspond to indoleamine 2,3-dioxygenase in stomach tumor microenvironment.

Authors:  Fangxuan Li; Jinchao Huang; Shixia Li; Hui Li; Jinpu Yu; Xiubao Ren; Juntian Liu
Journal:  Tumour Biol       Date:  2014-05-29

4.  The correlation between the subsets of tumor infiltrating memory T cells and the expression of indoleamine 2,3-dioxygenase in gastric cancer.

Authors:  Rupeng Zhang; Hui Liu; Fangxuan Li; Hui Li; Jinpu Yu; Xiubao Ren
Journal:  Dig Dis Sci       Date:  2013-08-25       Impact factor: 3.199

5.  Promoting long-term survival of insulin-producing cell grafts that differentiate from adipose tissue-derived stem cells to cure type 1 diabetes.

Authors:  Shuzi Zhang; Hehua Dai; Ni Wan; Yolonda Moore; Zhenhua Dai
Journal:  PLoS One       Date:  2011-12-28       Impact factor: 3.240

6.  Indoleamine 2,3-dioxygenase 2 depletion suppresses tumor growth in a mouse model of Lewis lung carcinoma.

Authors:  Wakana Yamasuge; Yasuko Yamamoto; Hidetsugu Fujigaki; Masato Hoshi; Kentaro Nakamoto; Kazuo Kunisawa; Akihiro Mouri; Toshitaka Nabeshima; Kuniaki Saito
Journal:  Cancer Sci       Date:  2019-09-25       Impact factor: 6.716

Review 7.  Contribution of IDO to human respiratory syncytial virus infection.

Authors:  Felipe M Benavente; Jorge A Soto; Magdalena S Pizarro-Ortega; Karen Bohmwald; Pablo A González; Susan M Bueno; Alexis M Kalergis
Journal:  J Leukoc Biol       Date:  2019-05-15       Impact factor: 4.962

8.  Manipulating IL-2 availability amid presentation of donor MHC antigens suppresses murine alloimmune responses by inducing regulatory T cells.

Authors:  Shuzi Zhang; Hehua Dai; Ni Wan; Yolonda Moore; Zhenhua Dai
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

9.  Suppression of immunodominant antitumor and antiviral CD8+ T cell responses by indoleamine 2,3-dioxygenase.

Authors:  Mateusz Rytelewski; Courtney E Meilleur; Maryam Atef Yekta; Peter A Szabo; Nitan Garg; Todd D Schell; Anthony M Jevnikar; Shayan Sharif; Bhagirath Singh; S M Mansour Haeryfar
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

Review 10.  Memory T cells: strategies for optimizing tumor immunotherapy.

Authors:  Qingjun Liu; Zhongjie Sun; Ligong Chen
Journal:  Protein Cell       Date:  2020-03-27       Impact factor: 14.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.